Which routine laboratory tests should be ordered for a patient with erythrocytosis and a family history of hemochromatosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Routine Laboratory Testing for Erythrocytosis with Family History of Hemochromatosis

Order transferrin saturation and serum ferritin as the essential first-line tests, followed by HFE genetic testing (specifically for C282Y mutation) if iron studies are elevated. 1

Initial Iron Studies

The most recent EASL guidelines (2022) provide clear direction: transferrin saturation and serum ferritin are the mandatory first-step assessments for anyone with suspected hemochromatosis, including those with erythrocytosis and positive family history 1. This represents 100% consensus among experts.

Specific Thresholds to Trigger Further Testing

Based on guideline recommendations, proceed to genetic testing when:

  • Males: Transferrin saturation >50% AND ferritin >300 μg/L 1
  • Females: Transferrin saturation >45% AND ferritin >200 μg/L 1

The American College of Physicians suggests slightly different cutoffs (transferrin saturation >55% and ferritin >200 μg/mL) but the principle remains consistent [@2-11@].

Genetic Testing Strategy

For first-degree relatives with family history of hemochromatosis, genetic testing for HFE mutations (particularly C282Y) should be performed after obtaining informed consent 1. This has 100% expert consensus and is particularly relevant given your patient's family history.

What NOT to Order

  • Hepcidin measurement is NOT recommended (100% consensus against) 1
  • Liver biopsy is no longer routinely needed with genetic testing availability [@2-11@]

Additional Considerations for Erythrocytosis Workup

While addressing the hemochromatosis concern, don't overlook the erythrocytosis itself:

  • Erythropoietin (EPO) level - helps distinguish primary from secondary causes 2, 3
  • JAK2 mutation testing - essential to exclude polycythemia vera as the cause of erythrocytosis 4, 5
  • Peripheral oxygen saturation - screens for hypoxia-driven secondary erythrocytosis 2

Recent evidence (2026) suggests the TRAKJAK score can predict JAK2 mutation positivity and reduce unnecessary testing 4.

The Iron-Erythrocytosis Connection

This clinical scenario is particularly important because iron overload (including from hemochromatosis) can actually stimulate erythrocytosis 5. The 2026 literature specifically highlights this bidirectional relationship - your patient may have both conditions influencing each other.

Practical Testing Algorithm

  1. Immediate labs: Transferrin saturation + serum ferritin
  2. If elevated per thresholds above: HFE genotyping (C282Y and H63D)
  3. Simultaneously for erythrocytosis: EPO level, JAK2 mutation, oxygen saturation
  4. Optional supplementary: Serum iron and total iron binding capacity for differential diagnosis (87% consensus) 1

Critical Pitfall to Avoid

Do not assume the family history alone justifies skipping iron studies and going straight to genetic testing. Biochemical confirmation (elevated transferrin saturation and ferritin) should precede genetic testing except in asymptomatic first-degree relatives where direct genetic testing is appropriate 1, 6.

The combination of erythrocytosis with hemochromatosis family history creates a unique diagnostic challenge requiring evaluation of both conditions, as they may be independent or pathophysiologically linked 5.

References

Research

[Systematic diagnosis of erythrocytosis].

Nederlands tijdschrift voor geneeskunde, 2007

Research

Secondary erythrocytosis.

Expert review of hematology, 2023

Research

[Diagnostic work-up of erythrocytosis].

La Revue de medecine interne, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.